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In a  previous communication from this  laboratory  (1),  it was shown that 
the intravenous injection of crude papain into young rabbits results in rapid 
depletion of the basophilic component of cartilage matrix throughout the body, 
resulting in loss of the normal rigidity of the rabbits' ears and consequent col- 
lapse of these structures.  Reconstitution of cartilage matrix,  with restoration 
of the ears to their usual appearance, occurs within several days. Recovery is 
prevented by the administration  of cortisone. 
These observations were extended by Spicer and Bryant (2),  who observed 
loss  of metachromasia  of cartilage  and  the  appearance  of amorphous,  baso- 
philic material in the pericartilaginous interstitial spaces, lymphatics and blood 
vessels; subsequently these workers described metachromatic material in other 
blood vessels  and  in  the  renal  tubules  (3).  Bryant,  Leder,  and  Stetten  (4) 
reported  the  isolation  of  a  mucopolysaccharide  with  the  characteristics  of 
chondroitin sulfate from the blood and urine of rabbits following an injection 
of papain. 
Our earlier investigations of the effect on cartilage failed to reveal the identity 
of the responsible component in crude papain.  Injections of large  amounts of 
crystalline papain protease containing  cysteine, or of crystalline papain  lyso- 
zyme, did not cause collapse  of rabbit ears,  and it was assumed that neither 
was the active constituent (1).  Recently, however, it was noted that some of 
the animals given crystalline protease developed histological  changes  suggest- 
ing  slight  depletion of the  matrix,  and  the possibility that  this  preparation 
contained  traces of active material  was therefore investigated.  In the course 
of this study, solutions of crystalline papain protease were inactivated by pro- 
longed dialysis against distilled water with removal of cysteine and consequent 
oxidation of the enzyme, or by the addition of two thiolantagonists,  p-chloro- 
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mercuribenzoate  and  iodoacetamide,  prior  to  injection.  Paradoxically,  such 
treatment was found to change the protease, so that all of the gross and histo- 
logical changes  caused by crude papain could now  be reproduced with  small 
amounts  of  the  crystalline  enzyme. 
The present report is concerned with a description of these findings, together 
with other evidence indicating that  the  component  of crude papain which  is 
responsible for  the  action  on  cartilage in  vivo is,  in  fact,  crystalline papain 
protease. 
Materials  and Methods 
Young, hybrid albino rabbits of both sexes, weighing between 800 and 1000 gin., were used 
in all experiments,  since it had been previously observed that mature animals are relatively 
refractory to the effects of papain (1). 
Crude papain was obtained from several commercial sources in the form of dry, powdered 
latex. An approximate 1 per cent solution  was prepared by stirring the powder in warm 
physiological saline and removing insoluble residue by paper filtration. In most instances,  the 
final solution contained approximately 4 mg./ml, of non-dialysable protein (as measured  by 
biuret and Kjeldahl determinations). 
Crystalline papain protease (2 X  crystallized), prepared according to the method of Kim- 
reel and Smith (5), was obtained from Worthington Biochemical company, Freehold, New 
Jersey, and from Nutritional Bioehemicals Corporation, Cleveland. The enzyme was received 
in saline solution containing 0.03 M cysteine. 
Assays of proteolytic activity of papain preparations were performed by the alcohol ti- 
tration technique  of Grassman and Heyde (6), as employed by Davis and Smith (7). The 
substrate was alpha benzoyl-L-argininamide (BAA),  1 which is deaminated by papain. Reac- 
tions were run at pH 7.0, at 37°C., using 0.05 M BAA. Under the conditions of assay, the hy- 
drolysis of BAA is a first order reaction.  Specific activity (C1) is expressed as Kx (first  order 
rate constant calculated in decimal logarithms)  per milligram of protein nitrogen per milli- 
liter  of  reaction mixture.  Cysteine,  versene  (ethylenediamine-tetraacetic acid dihydrate), 
iodoacetamide or p-chloromercuribenzoate  were added to the reaction mixtures under condi- 
tions described below. 
Bromelin,  a crude protease preparation derived from pineapple, was obtained from  Nu- 
tritional Biochemicals Corporation.  Solutions of this material were prepared in the same man- 
ner as for crude papain. 
Rabbit tissues were fixed in 10 per cent formalin and stained with hematoxyfin and eosin. 
In certain instances,  toluidine  blue was also used for staining. 
EXPERIMENTAL 
The Conditions under Which Cartilage Matrix is Removed by Crystalline Papain 
Protease, in Vivo 
In  our  previous  report  (1),  it was  stated  that  crystalline papain  protease 
failed to  produce  collapse of  rabbit ears,  even  when  injected in  amounts  as 
large  as  10  rag.  All of  the  preparations  tested  contained  cysteine,  to  insure 
activation of the enzyme.  In  the  present study, it was learned that when the 
cysteine  was  removed,  or  the  enzyme  inactivated  by  treatment  with  thiol 
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antagonists, the same in vivo action on cartilage as had been encountered with 
crude papain became readily demonstrable with the crystalline protease. The 
point  is  illustrated by  the  following experiments. 
The in Vivo Activity of Dialyzed Preparations of Crystalline Papain Protease.-- 
A solution of crystalline protease, originally containing 0.03 ~s cysteine,  was dialyzed for 
16 hours against repeated changes of distilled water. At the end of this time, the preparation 
showed a tenfold diminution of proteolytic activity in vitro. Four rabbits were injected by 
vein with 4 rag. of the dialyzed material. Four others received the same preparation, but with 
the addition of 0.03 M cysteine and 0.001 M versene. 
TABLE I 





Substance added to 
enzyme solution 
None 
0.03 ~ cysteine 















No. of rabbits 




Enzyme solution dialyzed against distilled water for 16 hours. 
100 
* Ca =  K, IR; Ka = 1/t log ~  inwhich X is the per cent of substrate (a-benzoyl- 
L-argininamide)  hydrolyzed at time t. E  =  enzyme concentration in milligrams of protein 
N per milliliter. 
Solutions incubated for 15 minutes at 37  ° before injection. Results recorded at 24 hours. 
The results are shown  in Table I. All of the rabbits receiving the dialyzed 
enzyme exhibited collapse of the ears (Fig. 1) and histological sections showed 
depletion of cartilage matrix. In contrast, none of the animals given dialyzed 
enzyme  to which  cysteine and  versene were  added developed ear collapse or 
cartilage changes,  indicating that  reduction, or  "activation," of the protease 
before injection results in loss of its capacity to affect cartilage in vivo. 
The in  Vivo Activity of Crystalline Protease  after  Treatment with Sulfkydryl- 
Blocking  Agents.--Results  compatible  with  the  above  were  obtained  when 
crystalline  papain  protease  was  inactivated  by  p-chloromercuribenzoate 
(PCMB) 2 or iodoacetamide (IAA)  3 before being injected, as is shown  by the 
following experiment. 
Solutions of crystalline protease were incubated in the presence of various concentrations 
of PCMB or IAA for 15 minutes at 37°C. Groups of four rabbits each were injected intra- 
PCMB, p-chloromercuribenzoate. 
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venously with the treated enzyme, while similar groups of control animals received untreated 
material. The results are summarized in Table II. 
Ear  collapse,  accompanied  by  typical histological alterations  in  cartilage, 
occurred in all the animals receiving crystalline protease treated with the thiol 
antagonists, while no changes were seen in the rabbits given untreated protease. 
Assays of proteolytic activity in ~itro yielded results comparable with those 
obtained with protease before and after dialysis. For example, as is shown in 
Table II, the C1  value of untreated enzyme was 0.4 (this preparation caused 
TABLE II 
The in Vi~o Effect on Cartilage of Crystalline Papain Treated  with Iodoacetamid¢ 
or p-Chlororaercuribenzoate 
DOSe  • 
ml. 
10 
Substance added to 
enzyme solution 
0.03 M cysteine 
0.001  M versene 
None 
0.005 g  IAA 
0.06 g  IAA 
0.001  ~s PCMB 
None 
0.3 ~ IAA 
0.0005  ~ IAA 








No. of  rabbits 
rabbits  with ear 
collapse 
No. of rabbits 




Crystalline papaln diluted in 0.05 ~  phosphate buffer pit 7 so  as to contain 5 mg./ml 
of enzyme and 0.006 M cysteine. All solutions incubated for 15 minutes at 37  ° prior to in- 
jection. IAA ~  iodoacetamide; PCMB  --  p-chloromercuribenzoate.  Results recorded at 
24 hours. C1 -- Kl/s. 
no changes in cartilage in vivo), while the C1 after treatment with 0.005 ~r IAA 
was decreased to 0.01  (this preparation produced typical ear collapse). 
It is to be noted that these results were seen with very high concentrations 
of iodoacetamide, indicating that in addition to binding cysteine in the enzyme 
diluent,  the  IAA  reacted  directly  with  the  enzyme.  This  was  shown  more 
directly in  the following experiment. 
Solutions of crystalline papaln were dialyzed against distilled water for 20 hours to remove 
the cysteine. To such solutions, IAA was added in concentrations of 0.005 or 0.01 5. In ~itro 
assays using BAA hydrolysis showed that such preparations possessed no activity, nor was 
there any return of activity upon addition of 0.1 ~s cysteine and 0.001 ~ versene. 
The  results following injection of  IAA-treated dialyzed crystalline papain 
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occurred following such treatment. This indicates that reversal of IAA inactiva- 
tion of crystalline papain takes place in the rabbit. 
The Effects of Thiol Antagonists and Cysteine, on the in Vivo Activity of Crude 
Papain Solutions.--The foregoing experiments indicated that crystalline papain 
protease  does not bring about depletion  of cartilage  matrix in vivo if injected 














addition of 0.03 









No. of rabbits 




Crystalline papain solution dialyzed against distilled water for 20  hours. IAA  --  iodo- 
acetamide. Enzyme solutions incubated for 15  minutes at  37°C.  before injection. Results 
recorded at 24 hours. 
* Cysteine not added to enzyme solution injected. 
TABLE IV 





Cystelne  Versene 
0.1 M  0.001  ~r 
None  None 
No. of  No. of rabbits  No. of rabbits with 
collapse  staining  cartilage 
0 
4 
* Milligrams protein  crude  papain.  Enzyme  solutions incubated  15  minutes at  37°C. 
before injection. Results recorded at 24 hours. 
the  same  is  true  for  a  solution  of  crude  papain.  Accordingly,  the  following 
experiment was  performed:-- 
A 1 per cent solution of crude papain was divided into two aliquots. To one, cysteine HC1 
(0.1  u)  and versene (0.001 ~r)  were added. Each aliquot was then injected by vein into a 
group of 4 rabbits. 
As is shown in Table IV, ear collapse did not occur in any of the animals 
injected with the reduced crude papain, while all of the controls showed typical 
reactions. 
It was also found that the addition of PCMB or IAA to crude papain solu- 
tions did not interfere with the capacity to produce  ear collapse. Indeed, in 
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somewhat more rapidly and completely in such rabbits, as might be predicted 
on the basis of the observed effects of thiol antagonists on the crystalline pro- 
tease. 
Studies on the Action of Crystalline Papain Protease on Isolated Rabbit 
Ear Cartilage 
The Direct Action of Crystalline  Papain Protease on Rabbit Ear Cartilage.- 
Rabbit ear cartilage was isolated and placed in solutions of crystalline papain protease 
containing thiol or antithiol agents, in order to learn whether changes occurred similar to 
those observed in the living animal. 
Within 2 hours after immersion at 37°C. in solutions containing 0.1 rag. crystalline papain, 
0.005 ~¢ cystdne and 0.001 xr versene, the ear cartilage had become completely flaccid and 
collapsed. In contrast, cartilage placed in papain containing 0.001 ~ IAA or 0.0001 ~¢ PCMB 
remained erect and without loss of normal tone. 
Histological sections of the ear cartilage undergoing collapse in vitro showed 
changes strikingly similar to those seen in vivo. The basophilic component of 
the cartilage matrix disappeared completely, while the cartilage cells remained 
intact.  The  cartilage  samples placed  in  papain  containing  thiol  antagonists 
showed no loss of basophilia in  the matrix. 
These results may seem at first to conflict with those observed in the living 
rabbit, since here the reduced papain protease is active against cartilage matrix 
while the enzyme treated with antithiol compounds is ineffective. However, it 
will be shown in the sections to follow that the conflict is not a real one, since 
the in vivo action of papain protease also requires  that  the  enzyme undergo 
reduction once it has succeeded in reaching cartilage. 
In  Vitro Action of Papain Protease in the Cartilage of Isolated Rabbit Ears, 
Amputated  after  Intravenous  Injection  of Emyme.--Earlier  experiments  had 
suggested that the active component of crude papain is rapidly cleared from 
the  circulating  blood,  presumably  being  taken  up  in  considerable  part  by 
cartilage. When the arterial blood supply to one ear was clamped off just before 
the  intravenous  injection  of  papain  into  a  vein  elsewhere,  and  the  clamp 
released  15 minutes later,  this ear failed to undergo collapse, indicating  that 
insufficient papain remained in the blood after this lapse of time (1). 
In the light of this finding, it became of interest to learn whether the enzyme 
had actually been taken up by cartilage soon after injection.  One way to do 
this was to determine whether the same change in cartilage that occurs in vivo 
would proceed in vitro if an ear were surgically removed and incubated.  The 
following experiment was therefore performed: 
Three groups of rabbits were injected in the femoral vein with 5 rag. crude papain. Thirty 
minutes later the ears were removed. At this time they showed no loss of rigidity. One set 
was propped upright at 37°C. and observed at frequent intervals, the second set at  20°C., 
and the third at 4°C. The results are illustrated in Fig. 2. ROBERT  T.  McCLUSKEY  AND  LEWIS  THOMAS  377 
All of the ears kept at 37°C. showed curling of the distal portion at 3 or 4 
hours, and were completely collapsed and limp by the end of 18 hours. Histo- 
logical sections at this time showed disappearance of all basophilia from the 
cartilage matrix, and amorphous accumulations of basophilic, metachromatic 
material in the connective tissue adjacent to cartilage. The ears held at 20°C. 
showed much less collapse, with curling only of the distal 2 or 3 cm. portion, 
and histologically a  larger amount of basophilic matrix was still present. The 
ears placed at 4°C. showed no collapse, and no microscopic alteration in the 
cartilage. 
Control ears, from animals not injected with papain, did not exhibit collapse 
nor histological alterations when kept for 20 hours at any of the temperatures 
employed in the experiment. 
Similar in vitro collapse was demonstrated in rabbit ears removed 30 minutes 
after intravenous injection, into the femoral vein, of dialyzed crystalline papain 
protease (2 rag.) and protease treated with IAA or PCMB, suggesting that the 
purified enzyme had become incorporated into  the cartilage after  injection. 
With this information, it now became possible to carry out more direct experi- 
ments into the nature of the events involved in ear collapse. 
The E~ect of Thiol and Antithiol Co~npounds on Ear Cartilage Ranoved after 
Intravenous Injection of Papain Protease.--In order to learn whether the injected 
enzyme was dependent on SH groups  in producing  the  change in  cartilage 
matrix, the effects of cysteine, IAA, and PCMB brought into contact with the 
cartilage were studied in the following experiments:-- 
Rabbits were injected, in the femoral vein, with 5 rag. crude papain. Thirty minutes later 
the ears were removed and  the  skin and  connective tissues  were  stripped  away from the 
cartilage. One isolated cartilage plate from each animal was then placed upright in wide test 
tubes containing either of the following: cysteine HC1 (0.005 M) and versene (0.001 M), IAA 
(0.002 M), PCMB  (0.002 M), each in 0.05 M phosphate buffer at pH 7.  As controls, cartilage 
plates from the opposite ears were placed in phosphate  buffer alone. The  cartilage plates 
were kept at room temperature and observed at intervals during the next 20 hours. 
The results are illustrated in Tables V and VI. It will be seen that the pres- 
ence of cysteine and versene greatly enhanced the rate and severity of collapse 
of the cartilage plate in vitro, while both IAA and PCMB completely prevented 
collapse from occurring. These results were confirmed by histological study of 
the cartilage; gross collapse and limpness were accompanied by loss of baso- 
philic matrix, while retention of rigidity was associated with normal matrix. 
The  same  experiment  was  performed with  isolated  cartilage  plates  from 
rabbits injected 30 minutes previously with crystalline papain protease treated 
with IAA or PCMB, and similar results were obtained, as shown in Tables V 
and VI. Immersion of the cartilage plates in solutions containing cysteine and 
versene caused accelerated collapse and loss of matrix, while exposure to IAA 
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Absence  of  in  Vitro  Cartilage  Effect  after  Intravenous  Injection  of Reduced 
Papain  Protease.--Having  previously  demonstrated  that  crystalline  papain 
protease  containing  cysteine  failed  to  produce  ear collapse in vivo,  while  dia- 
lyzed protease  preparations  were active in  this  respect,  it  was  of  interest  to 
learn whether  corresponding  events occurred in vitro, in the isolated ear carti- 
lage. 
TABLE V 
Effect o/Cysteine and Versene on Rate of Collapse in Isolated Rabbit Ears 
Enzyme preparation injected  Ear in cysteine  Ear in buffer 
and versene 
Crude papain 5 mg  ........................................ 
Crystalline papain, 4 rag. with 0.005 x¢ IAA  .................. 
Crystalline papain, 4 rag. with 0.001 xt PCMB ............... 






Ears excised 30 minutes after injection and kept at room temperature.  Results recorded 
at  4  hours.  ++  collapse  distal  3  to  4  cm.  of  ear;  --  ear  erect.  Test  ear  placed 
in 0.05  M phosphate  buffer pH  7 which contained 0.005  ~  cysteine and  0.001  M versene; 
opposite ear placed in phosphate buffer alone. 
TABLE VI 
Effect o/lodoacetamide or p-Chloromercuribenzoate on Rate o/Collapse in Isolated 
Rabbit Ears 
Enzyme preparation injected  Ear in IAA or PCMB 
Crude papain, 5 mg  .................................  IAA--* 
Crude papain, 5 mg  .................................  PCMB-- 
Crystalline papain, 4 rag. with 0.005 •  IAA  ............  IAA-- 
Crystalline papain, 4 rag. with 0.005 g  IAA  ............  PCMB-- 





Ears  excised 30 minutes following injection and  kept at room temperature.  Results re- 
corded at 20 hours. 
*  --  ear erect. 
:~ ++  collapse of distal 3  to 4  cm.  of ear.  Test ear placed in 0.05  x¢ phosphate  buffer 
pH  7 which contained  either p-chloromercuribenzoate  (PCMB)  0.002  x¢ or iodoacetamide 
(IAA) 0.002 x,; opposite ear placed in plain buffer. 
Three rabbits were therefore injected by vein with 4 mg. crystalline protease in  a  solution 
containing 0.03  x¢ cysteine, while three others received the same quantity  of protease from 
which the cysteine had been removed by dialysis. Thirty minutes later, the ears were removed 
and the cartilage plates placed in buffer containing 0.03 x¢ cysteine. 
No  changes  occurred  in  the  cartilage plates  from  the  rabbits  injected  with 
papain  containing  cysteine,  while  complete  collapse  took  place within  a  few 
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The observations indicated  that the reduced papain had failed to be taken 
up by cartilage after intravenous injection. The significance of this will be dealt 
with  in  the  Discussion  section  below. 
Demonstration of in Vivo Depletion of Cartilage  Matrix with 
IAA-Treated Bromelin 
In earlier experiments, solutions of crude bromelin had been found to cause 
no changes in cartilage when injected intravenously. In the light of the findings 
with  papain  described  above,  new  experiments  along  comparable lines were 
undertaken with bromelin. 
TABLE VII 
In Vivo E~ect on Cartilage of IAA Treated Bromelin 
Enzyme  preparation  injected  No. of rabbits with  No. of rabbits  loss of basophilic 
No. of rabbits  with ear collapse  staining of cartilage 
Crude bromelin, 6 mg  ...................  [  4  0  0 
Crude bromelin with 0.0l M IAA 6 mg  .... [  4  4  4 
Solutions incubated for 15 minutes at 37  °. Results recorded at 24 hours. IAA =  iodo- 
acetamide. 
A 1 per cent solution of crude bromelin was prepared, and 0.005 ~t iodoacetamide was 
added to an aliquot. The IAA-treated enzyme was then injected intravenously into rabbits, 
and the results compared with those in animals injected with untreated bromelin. 
The outcome is shown in Table VII. All of the rabbits given IAA-treated 
bromelin  showed  complete  collapse  of  their  ears  within  several  hours,  and 
histological  sections  revealed  the  same  changes  in  cartilage  matrix  as  with 
papain. It is evident that bromelin contains an enzyme, or enzymes, with the 
same property with respect to cartilage as papain protease. Further studies on 
this  material  are now  in  progress. 
DISCUSSION 
The  intravenous  injection  of  crystalline  papain  protease  produces  rapid 
depletion of cartilage matrix in young rabbits, provided the enzyme is inacti- 
vated by oxidation or sulfhydryl blocking agents prior to injection. 
The paradox of the production of marked in vivo changes in cartilage following 
injection of inactivated, but not of activated, crystalline papain is clarified by 
study of the activity of the enzyme in cartilage. Such studies can be performed 
on plates of ear cartilage removed shortly after injection,  since the enzyme is 
rapidly taken up by cartilage and continues to produce its characteristic gross 
and histological changes when the cartilage is incubated in vitro. By exposing 
the isolated cartilage  to solutions containing either  cysteine or the sulfhydryl 
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that once the enzyme has been taken up by cartilage it is active in the reduced 
state and is inhibited by antithiol agents. In these respects, its behavior now 
resembles the proteolytic activity of crystalline papain in vitro (5). Exposure of 
normal rabbit cartilage in vitro to solutions containing crystalline papain pro- 
duces the same morphological  changes  in cartilage as are seen in vivo, and in 
this situation the effect is also accelerated by cysteine and inhibited by sulf- 
hydryl blocking agents. 
The failure of reduced crystalline or crude papain to produce in vivo changes 
in cartilage suggests that the enzyme does not reach cartilage in sufficient con- 
centration to cause detectable changes.  This interpretation is strengthened by 
the observation that when rabbits are injected with papain containing cysteine, 
their cartilage is not only unaffected in vivo, but also fails to undergo change 
when immersed in solutions containing  cysteine and versene. 
On these grounds, it is postulated that shortly following injection,  the reduced 
enzyme reacts with some component in the blood, perhaps a protein substrate, 
and this reaction somehow prevents passage of the enzyme from the blood to 
cartilage.  If injected in an inactive state,  this reaction in the blood does not 
take place, and the enzyme diffuses into cartilage where it becomes reactivated. 
The method by which the enzyme is inactivated prior to injection does not 
appear to be of importance. Similar results were obtained by removing cysteine 
from the enzyme solution by dialysis,  by mercaptide formation with PCMB or 
by alkylation with IAA. It is rather surprising  that  treatment  of crystalline 
papain with a large excess of iodoacetamide fails to eliminate its activity in vivo. 
The inactivation of crystalline papain by iodoacetamide is not reversed in vitro 
upon addition of reducing substances such as cysteine, and it is generally stated 
to  be irreversible.  It  was found  that  IAA-treated  crystalline  papain,  which 
showed no return of activity in vitro following addition of cysteine and versene, 
produced the characteristic gross and histological  changes in cartilage following 
injection. This indicates that IAA-treated papain is reactivated in the rabbit. 
The mechanism by which this occurs is not known, but warrants further in- 
vestigation. It has been reported that iodoacetamide does not cause destruction 
of the enzyme and  that  following precipitation  of iodoacetamide-inactivated 
papain with alcohol,  the activity may be restored almost to its original  level 
with cysteine (8). 
The high state of purity of crystalline papain (9) makes it unlikely that the 
effects are due to an impurity in the preparations  used. However, if an im- 
purity is, in fact responsible  for the effects on cartilage,  its properties must be 
remarkably similar  to those of papain protease itself,  in view of the findings 
with respect to activation by thiol and inactivation by antithiol substances in 
the in vitro studies on isolated cartilage plates. 
The  gross  and  histological  changes  in  cartilage  which  follow  injection 
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duced by crude papain. The amount of crystalline papain required to produce 
the change, however, is approximately the same as the amount of crude papain 
in terms of protein, using the relatively crude index of ear collapse as a measure 
of the effect on cartilage. With both crude and crystalline papain, ear collapse 
generally occurs with injections of 2 rag. of protein, but usually not with 1 mg. 
The failure to obtain increase in activity with the crystalline enzyme may be 
due to two factors, aside from the possibility that an impurity in the prepara- 
tion of crystalline papain is the active factor. First, there may be inhibitors in 
crude papain which are more effective in "protecting" the enzyme in the blood 
than those tried with crystalline papain, thus permitting a larger percentage of 
the injected material to diffuse into cartilage. Secondly, the possibility that 
other components of crude papain may produce the changes seen in cartilage 
cannot be  excluded. The fact  that  another plant  enzyme, bromelin,  causes 
identical changes demonstrates that crystalline papain is not the only enzyme 
which can do so. 
The chemical nature of the change produced in cartilage by papain has not 
been determined. It is known that chondroitin sulfate exists in cartilage in large 
part in the form of a mucoprotein, the protein moiety of which is not collagen 
(10). Tsaltas has shown, in this laboratory, that there is a considerable reduc- 
tion in  the chondroitin sulfate content of cartilage following an injection of 
crude papain  (11).  The appearance of metachromatic material in pericartilag- 
inous connective tissue, which occurs in the first several hours after injection, 
suggests that chondroitin sulfate is being liberated from cartilage in a state of 
relatively high polymerization. The isolation by Bryant, Leder, and Stetten 
(4)  of a  mucopolysaccharide with  the  characteristics  of chondroitin sulfate 
from the  blood and  urine  of papain-injected  rabbits  strengthens  this  inter- 
pretation. The latter workers suggest that papain acts on the protein moiety of 
the mucoprotein of cartilage, with dissociation of chondroitin sulfate and its 
diffusion out of cartilage. It has been reported that crystalline papain causes 
reduction in the viscosity of a protein-chondroitin sulfate complex in vitro (12). 
Further in vitro studies on the effect of crystalline papain on cartilage and on 
the mucoprotein of cartilage are in progress. 
Finally, a  word should be said about the general implications of the obser- 
vations  described  above.  It  has  been  shown  that  a  substance  with  potent 
biological properties, capable of producing extensive morphologic changes in a 
vulnerable tissue widely distributed throughout the body, can only do so if it 
is  injected in  an  inactive state.  If it  is  activated before injection,  it never 
succeeds in reaching the target tissue. Its effects seem to be dependent, to a 
crucial degree, on the capacity of the tissue itself to bring about activation of 
the enzyme. The possibility that this seemingly paradoxical situation may have 
a  counterpart  in  other mechanisms of  tissue damage is  one which deserves 
mention. 382  RE~OVAL OF CARTILAGE MATRIX, IN" VIVO, BY PAPAIN 
SUMMARY 
The intravenous injection of crystalline papain into young rabbits results in 
depletion  of cartilage  matrix  throughout  the body, with  loss of rigidity  and 
collapse of the ears, provided the enzyme is inactivated by oxidation or sulf- 
hydryl blocking agents prior to administration.  Cysteine-activated crystalline 
papain,  when injected intravenously, produces little or no change in cartilage. 
The  changes which occur in cartilage  following an injection  of inactivated 
crystalline papain are indistinguishable  from those produced by crude papain. 
Activation of crude papain by cysteine prior to injection results in loss of its 
capacity to produce in vivo changes in cartilage. 
The progressive changes which take place in cartilage in vivo also occur in 
vitro in isolated rabbit ears removed shortly after an injection of crude papain 
or inactivated crystalline papain.  In vitro ear collapse occurs rapidly at 37°C. 
and does not occur at 4°C. Collapse is enhanced by exposing the cartilage  to 
cysteine  and  prevented  by exposure  to  iodoacetamide  or  p-chloromercuri- 
benzoate. 
The direct action of crystalline papain on plates of normal cartilage, in vitro, 
results in the same gross and histological changes which were observed in vivo. 
The direct action is accelerated by cysteine and inhibited  by iodoacetamide or 
p-chloromercuribenzoate. 
The  intravenous  injection  of iodoacetamide-treated  bromelin  produces  the 
same in vivo changes in cartilage as papain. Untreated bromelin has no demon- 
strable effect on cartilage. 
It is suggested that  the reason for the failure of activated papain  to enter 
cartilage,  after being injected intravenously,  is that it probably reacts with a 
substrate or substrates in the blood. Oxidized or otherwise inactivated papain, 
in contrast,  is readily taken up by cartilage and there converted to its active 
form. 
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EXPLANATION  OF PLATES 
PLATE 26 
FIGS. i A and 1  B. Appearance of rabbits  given  4 rag.  dialyzed  crystalline  papain. 
FIG. 1  A. 4 hours after  iniection.  X  ~. 
FIG.  1 B.  16  hours  after  injection. X  ~. THE JOURNAL  OF EXPERIMENTAL MEDICINE  VOL.  108  PLATE  26 
(McCluskey and Thomas: Removal of cartilage matrix, in vivo, by papain) PLATE 27 
FIGS. 2 A  and 2 B.  Appearance of  isolated rabbit ears removed 30  minutes after 
injection of crude papain. Photographed 18 hours after injection. X  1. 
FIG. 2 A.  Erect ear kept at 4°; opposite ear partially collapsed, kept at 20 °. 
FIG. 2 B.  Erect ear kept at 4°; opposite ear, totally collapsed, kept at 37 °. THE JOURNAL  OF EXPERIMENTAL MEDICINE  VOL.  108  PLATE  27 
(McCluskey and Thomas: Removal of cartilage matrix, in vivo, by  papain) 